Theralase Technologies Market Cap

Theralase Technologies has a market cap or net worth of $34.11 million as of April 28, 2025. Its market cap has increased by 22.37% in one year.

Market Cap

34.11M

Enterprise Value

34.13M

Revenue

718.24K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.14

Market Cap Chart

Since April 2, 1996, Theralase Technologies's market cap has increased from 6.14M to 34.11M, an increase of 455.43%. That is a compound annual growth rate of 6.07%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	34.11M	-25.25%
Dec 31, 2024	45.64M	50.64%
Dec 28, 2023	30.29M	-40.82%
Dec 30, 2022	51.19M	-15.43%
Dec 31, 2021	60.53M	98.73%
Dec 31, 2020	30.46M	-43.12%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Nika Pharmaceuticals	1.02B
Veradigm	746.57M
Glass House Brands	469.11M
Elite Pharmaceuticals	439.57M
Northwest Biotherapeutics	427.93M
CytoDyn	284.08M
BioStem Technologies	242.70M

Market Cap Rankings